Cereius aims to improve the lives & survival of patients facing solid tumor brain metastasis through the use of personalized and highly targeted radiotherapy.
Cereius, Inc. Announces $6.75 Million Financing Proceeds to Advance Novel Therapies for Treating Solid Tumor Brain Metastasis https://t.co/xeoQrE9d5f via @PRWeb
Duke startup Cereius (Michael Zalutsky, Prof of Radiology & Kimberly Blackwell, Adjunct Prof of Med) just raised $6.7M to advance Duke-invented therapies for treating solid tumor brain metastases. https://t.co/Pgo5XiR8Qt
$$ for robotics, brain tumor therapies, 4 start-ups on the move in @DukeEngineering, working with GE Healthcare, and getting your software/med devices off the ground! Check out how @DukeU has innovated this month
@DukeMedSchool@Duke_CTSI@DukeMobileApps https://t.co/u0kVOgRvgh